Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Canagliflozin ameliorates renal oxidative stress and inflammation by stimulating AMPK-Akt-eNOS pathway in the isoprenaline-induced oxidative stress model.
Sci Rep. 2020 Sep 4;10(1):14659. doi: 10.1038/s41598-020-71599-2.
Sci Rep. 2020.
PMID: 32887916
Free PMC article.
Canagliflozin attenuates isoprenaline-induced cardiac oxidative stress by stimulating multiple antioxidant and anti-inflammatory signaling pathways.
Hasan R, Lasker S, Hasan A, Zerin F, Zamila M, Chowdhury FI, Nayan SI, Rahman MM, Khan F, Subhan N, Alam MA.
Hasan R, et al. Among authors: zerin f.
Sci Rep. 2020 Sep 2;10(1):14459. doi: 10.1038/s41598-020-71449-1.
Sci Rep. 2020.
PMID: 32879422
Free PMC article.
Item in Clipboard
Neflamapimod induces vasodilation in resistance mesenteric arteries by inhibiting p38 MAPKα and downstream Hsp27 phosphorylation.
Pandey AK, Zerin F, Menon SN, Tithi TI, Nguyen KP, Vo T, Daniel ML, Hafez S, Alam MA, Hasan R.
Pandey AK, et al. Among authors: zerin f.
Sci Rep. 2022 Mar 22;12(1):4905. doi: 10.1038/s41598-022-08877-8.
Sci Rep. 2022.
PMID: 35318382
Free PMC article.
Item in Clipboard
Item in Clipboard
Item in Clipboard
Dapagliflozin induces vasodilation in resistance-size mesenteric arteries by stimulating smooth muscle cell KV7 ion channels.
Hasan A, Menon SN, Zerin F, Hasan R.
Hasan A, et al. Among authors: zerin f.
Heliyon. 2022 May 20;8(5):e09503. doi: 10.1016/j.heliyon.2022.e09503. eCollection 2022 May.
Heliyon. 2022.
PMID: 35647331
Free PMC article.
Item in Clipboard
Mechanism of canagliflozin-induced vasodilation in resistance mesenteric arteries and the regulation of systemic blood pressure.
Hasan A, Zerin F, Menon SN, Alam MA, Hasan R.
Hasan A, et al. Among authors: zerin f.
J Pharmacol Sci. 2022 Dec;150(4):211-222. doi: 10.1016/j.jphs.2022.09.004. Epub 2022 Sep 24.
J Pharmacol Sci. 2022.
PMID: 36344043
Free article.
Item in Clipboard
Neflamapimod inhibits endothelial cell activation, adhesion molecule expression, leukocyte attachment and vascular inflammation by inhibiting p38 MAPKα and NF-κB signaling.
Menon SN, Zerin F, Ezewudo E, Simon NP, Menon SN, Daniel ML, Green AJ, Pandey A, Mackay CE, Hafez S, Moniri NH, Hasan R.
Menon SN, et al. Among authors: zerin f.
Biochem Pharmacol. 2023 Aug;214:115683. doi: 10.1016/j.bcp.2023.115683. Epub 2023 Jul 8.
Biochem Pharmacol. 2023.
PMID: 37429422
Item in Clipboard
Cite
Cite